These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 688880)

  • 21. [Problems of postthymectomy-syndromes, e.g. myasthenia gravis (author's transl)].
    Janzen RW; Lachenmayer L; Fischer K
    Med Klin; 1977 Nov; 72(45):1931-7. PubMed ID: 303737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Reversible end-stage renal failure in systemic lupus erythematosus].
    Schurr D; Efrat R; Drukker A
    Harefuah; 1984 Nov; 107(10):281-2. PubMed ID: 6530170
    [No Abstract]   [Full Text] [Related]  

  • 23. [Systemic lupus erythematosus after thymectomy in myasthenia gravis].
    Cervinka P; Hrncír Z
    Vnitr Lek; 1992 May; 38(5):495-500. PubMed ID: 1509720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of preeclampsia and myasthenia: a case report.
    Hamaoui A; Mercado R
    J Reprod Med; 2009 Sep; 54(9):587-90. PubMed ID: 19947039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hemodialysis in advanced lupus nephritis (author's transl)].
    Tarumi Y; Hara I; Murakami M; Kurata N; Miyawaki S
    Nihon Naika Gakkai Zasshi; 1976; 65(5):471-7. PubMed ID: 988085
    [No Abstract]   [Full Text] [Related]  

  • 26. [Rheumatoid arthritis overlapping with lupus nephritis (author's transl)].
    Suzuki H; Sano M; Tojo S
    Nihon Jinzo Gakkai Shi; 1979 Feb; 21(2):81-90. PubMed ID: 470226
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of polstigmine on the status of the respiratory muscles and pulmonary function in patients with myasthenia gravis].
    Radwan L; Strugalska MH; Koziorowski A
    Pneumonol Pol; 1987; 55(11-12):499-503. PubMed ID: 3444736
    [No Abstract]   [Full Text] [Related]  

  • 28. The clinical course of end-stage renal disease in systemic lupus erythematosus.
    Jarrett MP; Santhanam S; Del Greco F
    Arch Intern Med; 1983 Jul; 143(7):1353-6. PubMed ID: 6870409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botulinum toxin for spasmodic torticollis in a patient with myasthenia gravis.
    Emmerson J
    Mov Disord; 1994 May; 9(3):367. PubMed ID: 8041381
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of chronic renal failure by means of routine hemodialysis].
    Tanchev I; Genov Kh; Kurlova E; Stavreva E; Tancheva D
    Vutr Boles; 1982; 21(3):53-61. PubMed ID: 7113186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of the quality of life of patients with systemic lupus erythematosus with and without endstage renal disease.
    Vu TV; Escalante A
    J Rheumatol; 1999 Dec; 26(12):2595-601. PubMed ID: 10606368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholinesterase inhibitors in myasthenia gravis.
    Lange MJ
    Practitioner; 1966 Mar; 196(173):448-53. PubMed ID: 5905423
    [No Abstract]   [Full Text] [Related]  

  • 33. Hemodialysis on end-stage lupus nephritis.
    Coplon N; Siegel R; Fries J
    Trans Am Soc Artif Intern Organs; 1973; 19():302-4. PubMed ID: 4579028
    [No Abstract]   [Full Text] [Related]  

  • 34. [Thoracic epidural block for upper abdominal surgery in a patient with myasthemia gravis (author's transl)].
    Neumark J; Smekal C; Haberzeth K
    Wien Klin Wochenschr; 1980 Mar; 92(7):240-3. PubMed ID: 7395236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pseudointernuclear ophthalmoplegia as a presenting feature of ocular myasthenia gravis.
    Nijsse B; Bettink MW; Neuteboom RF
    BMJ Case Rep; 2014 Jun; 2014():. PubMed ID: 24928935
    [No Abstract]   [Full Text] [Related]  

  • 36. [Current treatment of myasthenia gravis].
    de Assis JL
    Rev Paul Med; 1965 Oct; 67(4):231-42. PubMed ID: 5848156
    [No Abstract]   [Full Text] [Related]  

  • 37. [The association of myasthenia and disseminated lupus erythematosus. 2 cases].
    Schoenen J; Delwaide PJ
    Nouv Presse Med; 1976 May; 5(18):1185-8. PubMed ID: 775436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapy of myasthenia gravis with cholinesterase inhibitors--principles and pharmacologic monitoring].
    Henze T
    Fortschr Neurol Psychiatr; 1996 Mar; 64(3):110-21. PubMed ID: 8900891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Myasthenia gravis in an active 48-year-old woman, demonstrated clinically, electrically and serologically, well tolerated for 30 years, thanks to Prostigmine and Mestinon. Some theoretical and practical problems].
    Chesni Y
    Rev Med Suisse Romande; 1979 May; 99(5):289-90. PubMed ID: 119291
    [No Abstract]   [Full Text] [Related]  

  • 40. Prescription profile of pyridostigmine use in a population of patients with myasthenia gravis.
    Machado-Alba JE; Calvo-Torres LF; Gaviria-Mendoza A; Augusto MejíA-Vélez C
    Muscle Nerve; 2017 Dec; 56(6):1041-1046. PubMed ID: 28214292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.